481 studies found for:    "tetrasomy 18p" OR "Chromosomal Disorder"
Show Display Options
Rank Status Study
21 Completed Genetic Analysis of Fraser Syndrome and Fryns Syndrome
Conditions: Fraser Syndrome;   Fryns Syndrome;   Chromosomal Abnormalities;   Abnormalities, Multiple
Intervention:
22 Completed Evaluation of Patients With Unresolved Chromosome Abnormalities
Conditions: Abnormalities;   Failure to Thrive;   Mental Retardation;   Microcephaly
Intervention:
23 Suspended Relationship of Genetic Differences to the Development of Chromosome Abnormalities
Condition: Radiation Exposure
Intervention:
24 Completed Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
Conditions: Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute
Intervention: Drug: 5 azacytidine
25 Terminated Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Conditions: Acute Myeloid Leukemia (AML);   Acute Promyelocytic Leukemia (APL);   Refractory Anemia With Excess of Blasts (RAEB)
Intervention:
26 Unknown  Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Condition: Post-natal Cytogenetics
Intervention:
27 Completed
Has Results
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Condition: Myelodysplastic Syndromes
Intervention: Drug: lenalidomide
28 Completed
Has Results
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
Condition: Myelodysplastic Syndromes
Interventions: Drug: Lenalidomide 5 mg;   Drug: Lenalidomide 10 mg;   Drug: Placebo
29 Completed
Has Results
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy;   Behavioral: Behavior Therapy
30 Enrolling by invitation Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA
Condition: Trisomy 21
Intervention: Procedure: cell-free fetal DNA
31 Recruiting X-chromosome Inactivation, Epigenetics and the Transcriptome
Conditions: Turner Syndrome;   Klinefelter Syndrome;   Triple X Syndrome;   47 XYY Syndrome;   Aortic Aneurysm
Intervention:
32 Not yet recruiting RA-2 13-cis Retinoic Acid (Isotretinoin)
Conditions: Male Infertility;   Klinefelter's Syndrome;   Y-chromosome Microdeletions
Intervention: Drug: 13-cis retinoic acid
33 Unknown  The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
Condition: Myelodysplastic Syndromes
Intervention: Drug: lenalidomide
34 Terminated Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Conditions: Myelodysplastic Syndromes;   Acute Myelogenous Leukemia
Intervention: Drug: lenalidomide
35 Completed Comparison of Aneuploidy Risk Evaluations
Conditions: Pregnancy;   Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Turners Syndrome
Intervention:
36 Completed Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Down Syndrome (Trisomy 21);   Edwards Syndrome (Trisomy 18);   Patau Syndrome (Trisomy 13);   Turner Syndrome
Intervention:
37 Active, not recruiting Studying Chromosomes in Samples From Younger Patients With Neuroblastoma
Condition: Neuroblastoma
Intervention: Other: laboratory biomarker analysis
38 Terminated Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy
Conditions: Infertility;   Miscarriage
Intervention: Genetic: Preimplantation Genetic Diagnosis
39 Unknown  Metal Ions in Ceramic on Metal Total Hip Arthroplasty
Conditions: Osteoarthritis;   Avascular Necrosis;   Rheumatoid Arthritis;   Developmental Dysplasia of the Hip
Intervention:
40 Terminated Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Acute Myelogenous Leukemia
Interventions: Drug: Azacitidine;   Drug: Lenalidomide

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years